BrainCells, Proximagen deal

BrainCells will acquire exclusive, worldwide rights to develop and commercialize Proximagen's sabcomeline.

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE